Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Stock Statistics & Valuation Metrics

Jagsonpal Pharmaceuticals Ltd. has a market cap or net worth of INR 14.33B. The enterprise value is INR 14.90B.

Market Cap

INR 14.33B

Enterprise Value

INR 14.90B

Jagsonpal Pharmaceuticals Ltd. has 66,059,240 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

66,059,240

Owned by Insiders

―

Owned by Institutions

―

Jagsonpal Pharmaceuticals Ltd.’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 12.56%.

Return on Equity (ROE)

0.16

Return on Assets (ROA)

0.14

Return on Invested Capital (ROIC)

12.56%

Return on Capital Employed (ROCE)

0.17

Revenue Per Employee

2.21M

Profits Per Employee

332.17K

Employee Count

1,297

Asset Turnover

0.91

Inventory Turnover

7.13

The current PE Ratio of Jagsonpal Pharmaceuticals Ltd. is 31.87. Jagsonpal Pharmaceuticals Ltd.’s PEG ratio is -1.21.

PE Ratio

31.87

PS Ratio

4.52

PB Ratio

5.93

Price to FCF

58.08

Price to Operating Cash Flow

57.85

PEG Ratio

-1.21

In the last 12 months, Jagsonpal Pharmaceuticals Ltd. had revenue of 2.87B and earned 430.82M in profits. Earnings per share was 6.40.

Revenue

2.87B

Gross Profit

1.83B

Operating Income

486.30M

Pretax Income

575.18M

Net Income

430.82M

EBITDA

679.90M

Earnings Per Share (EPS)

6.40

In the last 12 months, operating cash flow was 246.75M and capital expenditures -980,000, giving a free cash flow of 245.77M billion.

Operating Cash Flow

246.75M

Free Cash Flow

245.77M

Free Cash Flow per Share

3.72

Jagsonpal Pharmaceuticals Ltd. pays an annual dividend of INR 2.50, resulting in a dividend yield of 1.84%

Dividend Per Share

INR 2.50

Dividend Yield

1.84%

Payout Ratio

26.82%

Free Cash Flow Yield

1.72%

Earnings Yield

3.17%

Beta

1.04

52-Week Price Change

-1.52%

50-Day Moving Average

229.98

200-Day Moving Average

206.49

Relative Strength Index (RSI)

42.56

Average Volume (3m)

13.36K

Jagsonpal Pharmaceuticals Ltd. upcoming earnings date is Feb 05, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 28, 2026

Next Earnings Date

Feb 05, 2027

Ex-Dividend Date

Sep 12, 2025

Jagsonpal Pharmaceuticals Ltd. as a current ratio of 5.06, with Debt / Equity ratio of 2.96%

Current Ratio

5.06

Quick Ratio

4.54

Debt to Market Cap

0.00

Net Debt to EBITDA

-0.03

Interest Coverage Ratio

47.31

In the past 12 months, Jagsonpal Pharmaceuticals Ltd. has paid 144.36M in taxes.

Income Tax

144.36M

Effective Tax Rate

0.25

Jagsonpal Pharmaceuticals Ltd. EV to EBITDA ratio is 20.13, with an EV/FCF ratio of 53.77.

EV to Sales

4.19

EV to EBITDA

20.13

EV to Free Cash Flow

53.77

EV to Operating Cash Flow

53.55

Jagsonpal Pharmaceuticals Ltd. has INR 1.06B in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 1.06B billion.

Cash & Marketable Securities

INR 1.06B

Total Debt

INR 0.00

Net Cash

INR 1.06B

Net Cash Per Share

INR 16.06

Tangible Book Value Per Share

INR 41.95

Gross margin is 46.08%, with operating margin of 16.63%, and net profit margin of 14.31%.

Gross Margin

46.08%

Operating Margin

16.63%

Pretax Margin

19.12%

Net Profit Margin

14.31%

EBITDA Margin

20.79%

EBIT Margin

17.92%

The average price target for Jagsonpal Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

11.71%

EPS Growth Forecast

-26.92%

Smart Score

―

AI Score

78